Graf Akcie CTIC (CTI BioPharma Corp). Diskuze k akciím CTIC. Aktuální informace CTIC.

Základní informace o společnosti CTI BioPharma Corp (Akcie CTIC)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 257.46M
Hodnota podniku (EV) 230.04M
Tržby 0.00
EBITDA -41.91
Zisk -63.21
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.08
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales N/A
P/FCF N/A
Price/Book 6.43
Účetní hodnota na akcii 0.43
Hotovost na akcii 0.56
FCF vůči ceně -21.98 %
Počet zaměstnanců 23
Tržba na zaměstnance 0.00
Profit margin N/A %
Operating margin N/A %
Gross margin N/A %
EBIT margin N/A %
EBITDA margin N/A %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 10.53 %
EPS - Očekávaný růst příští rok 66.67 %
Return on assets -104.64 %
Return on equity -144.30 %
ROIC -94.20 %
ROCE -101.91 %
Dluhy/Equity 0.45
Čistý dluh/EBITDA 4.86
Current ratio 4.74
Quick Ratio 4.74
Volatilita 3.84
Beta 0.28
RSI 44.03
Cílová cena analytiků 6
Známka akcie (dle analytiků) 1.00
Insider ownership 0.22 %
Institutional ownership 50.57 %
Počet akcií 93.31M
Procento shortovaných akcií 2.98 %
Short ratio 3.30 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1997
Země United States

Finanční výsledky akcie CTIC

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$3.345$26.29$25.146$57.405$16.116$60.077
Cost Of Goods Sold--$0.364$1.377$1.94$0.895
Gross Profit$3.345$26.29$24.782$56.028$14.176$59.182
Research And Development Expenses$24.107$36.467$32.866$64.961$76.627$64.596
SG&A Expenses$19.155$22.062$31.435$45.306$53.962$56.241
Other Operating Income Or Expenses---$5.077$-0.253$-2.719
Operating Expenses$44.056$59.189$64.665$106.567$132.782$146.31
Operating Income$-40.711$-32.899$-39.519$-49.162$-116.666$-86.233
Total Non-Operating Income/Expense$0.688$3.547$-1.312$-3.791$-4.097$-7.996
Pre-Tax Income$-40.023$-29.352$-40.831$-52.953$-120.763$-94.229
Income Taxes------
Income After Taxes$-40.023$-29.352$-40.831$-52.953$-120.763$-94.229
Other Income------
Income From Continuous Operations$-40.023$-29.352$-40.831$-52.953$-120.763$-94.229
Income From Discontinued Operations------
Net Income$-40.02$-29.4$-45.02$-52.009$-122.622$-95.992
EBITDA$-40.165$-32.306$-38.802$-48.331$-115.676$-85.133
EBIT$-40.711$-32.899$-39.519$-49.162$-116.666$-86.233
Basic Shares Outstanding585636281915
Shares Outstanding585636281915
Basic EPS$-0.69$-0.52$-1.24$-1.86$-6.51$-6.46
EPS - Earnings Per Share$-0.69$-0.52$-1.24$-1.86$-6.51$-6.46
# 2020 2019 2018 2017 2016 2015
Current Ratio1.92453.57812.43661.37341.86412.2153
Long-term Debt / Capital0.1990.1490.45760.59320.28740.1732
Debt/Equity Ratio0.51680.26590.87132.48291.19160.4353
Gross Margin10010098.552597.601387.962398.5102
Operating Margin-1217.07-125.1388-157.1582-85.6406-723.9142-143.5375
EBIT Margin-1217.07-125.1388-157.1582-85.6406-723.9142-143.5375
EBITDA Margin-1200.747-122.8832-154.3069-84.193-717.7713-141.7065
Pre-Tax Profit Margin-1196.502-111.647-162.3757-92.2446-749.3362-156.847
Net Profit Margin-1196.413-111.8296-179.0344-90.6001-760.8712-159.7816
Asset Turnover0.07230.29270.45810.89920.11180.651
Inventory Turnover Ratio---0.9030.68190.214
Receiveable Turnover-1.921919.67617.038457.148929.8742
Days Sales In Receivables-189.913818.550551.85866.386812.2179
ROE - Return On Equity-223.2162-55.445-253.7669-682.6373-254.7036-236.0267
Return On Tangible Equity-223.2181-55.4449-253.7663-682.6479-254.7044-236.0268
ROA - Return On Assets-86.4801-32.6743-74.3924-82.9425-83.7486-102.1043
ROI - Return On Investment-178.7938-47.1852-137.6403-277.7061-181.4975-195.1477
Book Value Per Share0.30920.9130.37450.27481.69052.2586
Operating Cash Flow Per Share0.23030.3681.66552.3103-2.39120.4748
Free Cash Flow Per Share0.23090.36881.6692.3096-2.3730.5867